Barringer Technologies Inc. Authorizes Repurchase of Up to an Additional 1,000,000 Shares of Common Stock; Total of 2,000,000 Shares Authorized for Repurchase.

MURRAY HILL, N.J.--(BUSINESS WIRE)--July 22, 1999--

Barringer Technologies Inc. (NASDAQ NMS: BARR, BARRW) today announced that its Board of Directors has authorized the repurchase of up to an additional 1,000,000 shares of the Company's outstanding common stock pursuant to the Company's previously announced share repurchase program.

With the increase announced today, the program will cover a total of 2,000,000 shares. Since the share repurchase program began in July 1998, the Company has repurchased an aggregate of 972,500 shares. After giving effect to the increased authorization, the Company will have the ability to repurchase up to 14.6% of the shares of common stock outstanding as of July 1, 1999. Any future repurchase of shares will be made from time to time in open market or privately negotiated transactions in such amounts as determined by the Company's management and will be funded out of the Company's working capital.]

Stanley S. Binder, Chairman and Chief Executive Officer of Barringer Technologies, said, "Our Board of Directors continues to believe that the recent trading price of the Company's common stock does not adequately reflect the Company's intrinsic value. Accordingly, by increasing the number of shares available to be purchased under the program, we hope to further enhance stockholder value through the repurchase of our shares at an advantageous price. We continue to believe that our stock represents an excellent long-term investment at its current market valuation."

Headquartered in Murray Hill, New Jersey, Barringer Technologies Inc. is principally engaged in the development, manufacture and marketing of high technology products for drugs and explosives detection and other security and industrial applications. The IONSCAN is the Company's proprietary trace particle detection unit. With over 1,200 IONSCAN units deployed in over 50 countries, Barringer Technologies Inc. is the world leader in trace detection based on the number of units deployed.

This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended that are based on the beliefs of the Company's management as well as assumptions made by and information currently available to the Company's management. When used in this press release, the words "estimate," "project," "believe," "anticipate," "intend," "expect," "plan," "predict," "may," "should," "will," the negative thereof and similar expressions are intended to identify forward-looking statements. Such statements reflect the current views of the Company with respect to future events based on currently available information and are subject to risks and uncertainties that could cause actual results to differ materially from those contemplated in such forward-looking statements. Factors that could cause actual results to differ materially from the Company's expectations include, but are not limited to, the following: general economic and political conditions, budgetary processes, the timing of government procurements, other conditions in the markets for the Company's products, unexpected manufacturing or shipping delays, and other factors that could delay delivery of IONSCAN(R) to the FAA. Other factors may be described from time to time in the Company's public filings with the Securities and Exchange Commission, news releases and other communications. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company does not undertake any obligation to release publicly any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.